Serumwerk Bernburg AG
Serumwerk Bernburg AG, commonly referred to as Serumwerk, is a prominent player in the pharmaceutical industry, headquartered in Bernburg, Germany. Founded in 1894, the company has established itself as a leader in the development and production of high-quality biopharmaceuticals, particularly in the fields of immunology and infectious diseases. With a strong operational presence across Europe, Serumwerk is renowned for its innovative core products, including vaccines and therapeutic proteins, which are distinguished by their rigorous quality standards and advanced manufacturing processes. The company has achieved significant milestones, including various certifications that underscore its commitment to excellence. Serumwerk Bernburg AG's dedication to research and development has solidified its market position, making it a trusted partner in the healthcare sector, known for its contributions to public health and patient care.
DitchCarbon Score
How does Serumwerk Bernburg AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Serumwerk Bernburg AG's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Serumwerk Bernburg AG's reported carbon emissions
Serumwerk Bernburg AG, headquartered in Germany, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and reducing their carbon footprints. It is essential for Serumwerk Bernburg AG to establish clear emissions reduction targets and strategies to align with industry standards and expectations. As the global emphasis on climate action intensifies, the company may benefit from developing a comprehensive approach to track and mitigate its carbon emissions in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Serumwerk Bernburg AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
